businesspress24.com - Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10
 

Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10

ID: 1438930

(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/01/16 -- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva''s President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Friday, June 10, at 11:00 a.m. ET at the Grand Hyatt Hotel, New York.

The presentation will be webcast live and can be accessed from Innoviva''s website at or from the following link: a replay of the presentation will be available following the presentation for 90 days.

Innoviva, formerly known as Theravance, Inc., is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva''s portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva''s website at .

ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the GlaxoSmithKline group of companies.

(INVA-F)



Eric d''Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Knight to Present at Both the National Bank Financial Quebec Conference in Montreal and the Jefferies Healthcare Conference in New York City
Marina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French
Bereitgestellt von Benutzer: Marketwired
Datum: 01.06.2016 - 14:05 Uhr
Sprache: Deutsch
News-ID 1438930
Anzahl Zeichen: 2449

contact information:
Contact person:
Town:

SOUTH SAN FRANCISCO, CA


Phone:

Kategorie:

Drugs


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 273 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10
"
steht unter der journalistisch-redaktionellen Verantwortung von

Innoviva (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Innoviva



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 70


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.